{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:21:51Z","timestamp":1793830911078,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1245\/s10434-018-6464-z","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T12:26:16Z","timestamp":1523363176000},"page":"1668-1675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE"],"prefix":"10.1245","volume":"25","author":[{"name":"the PSOGI Working Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0468-6778","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Mercier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the BIG-RENAPE Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoual","family":"Bakrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Goere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Quenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Heyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Marolho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"6464_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1056\/NEJM199601043340112","volume":"334","author":"JP Neijt","year":"1996","unstructured":"Neijt JP. New therapy for ovarian cancer. N Engl J Med. 1996;334:50\u20131.","journal-title":"N Engl J Med."},{"issue":"2","key":"6464_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s13193-016-0501-9","volume":"7","author":"A Bhatt","year":"2016","unstructured":"Bhatt A, Glehen O. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer: a review. Indian J Surg Oncol. 2016;7(2):188\u201397.","journal-title":"Indian J Surg Oncol."},{"issue":"7","key":"6464_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jso.21288","volume":"99","author":"J Sehouli","year":"2009","unstructured":"Sehouli J, Senyuva F, Fotopoulou C, Neumann U, Denkert C,Werner L, G\u00fclten O. Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer. J Surg Oncol. 2009;99(7):424\u20137.","journal-title":"J Surg Oncol."},{"key":"6464_CR4","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/cncr.24915","volume":"116","author":"A Bamias","year":"2010","unstructured":"Bamias A, Psaltopoulou T, Sotiropoulou M et al. Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy. Cancer. 2010;116:1462\u20138.","journal-title":"Cancer."},{"key":"6464_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3747\/co.2007.148","volume":"14","author":"M Fung-Kee-Fung","year":"2007","unstructured":"Fung-Kee-Fung M, Oliver T, Elit L, et al. Optimal chemotherapy treatment for women with recurrent ovarian cancer. Curr Oncol. 2007;14:195\u2013208.","journal-title":"Curr Oncol."},{"key":"6464_CR6","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","volume":"25","author":"WE Winter III","year":"2007","unstructured":"Winter WE III, Maxwell GL, Tian C, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:3621\u20137.","journal-title":"J Clin Oncol."},{"key":"6464_CR7","first-page":"611","volume":"27","author":"E Efstathoiou","year":"2007","unstructured":"Efstathoiou E, Dimopoulos MA, Bozas G, et al. Advanced epithelial ovarian cancer in the elderly. Anticancer Res. 2007;27:611\u20137.","journal-title":"Anticancer Res."},{"key":"6464_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ygyno.2005.12.038","volume":"102","author":"D Pectasides","year":"2006","unstructured":"Pectasides D, Fountzilas G, Aravantinos G, et al. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience. Gynecol Oncol. 2006;102:285\u201391.","journal-title":"Gynecol Oncol."},{"key":"6464_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1349-7006.2008.00747.x","volume":"99","author":"H Itamochi","year":"2008","unstructured":"Itamochi H, Kigawa J, Terakawa N. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci. 2008;99:653\u20138.","journal-title":"Cancer Sci."},{"key":"6464_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.path.2016.01.005","volume":"9","author":"L Witkowski","year":"2016","unstructured":"Witkowski L, Goudie C, Foulkes WD and McCluggage GW. Small-cell carcinoma of the ovary of hypercalcemic type (malignant rhabdoid tumor of the ovary) a review with recent developments on pathogenesis. Surg Pathol. 2016;9:215\u201326.","journal-title":"Surg Pathol."},{"issue":"12","key":"6464_CR11","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ejso.2015.08.172","volume":"41","author":"YR Huo","year":"2015","unstructured":"Huo YR, Richards A, Liauw W, Morris DL. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2015;41(12):1578\u201389.","journal-title":"Eur J Surg Oncol."},{"key":"6464_CR12","first-page":"49","volume":"15","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15:49\u201358.","journal-title":"J Exp Clin Cancer Res."},{"key":"6464_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res."},{"issue":"4","key":"6464_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","volume":"5","author":"O Glehen","year":"2004","unstructured":"Glehen O, Mohammed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 2004;5(4):219\u201328.","journal-title":"Lancet Oncol."},{"key":"6464_CR15","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. \n                    https:\/\/www.evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14\n                    \n                  ."},{"key":"6464_CR16","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248\u201359.","journal-title":"J Clin Oncol."},{"key":"6464_CR17","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1056\/NEJMe048292","volume":"351","author":"T Thigpen","year":"2004","unstructured":"Thigpen T. The if and when of surgical debulking for ovarian carcinoma. N Engl J Med. 2004;351:2544\u20136.","journal-title":"N Engl J Med."},{"issue":"9","key":"6464_CR18","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1097\/IGC.0000000000000007","volume":"23","author":"P Amate","year":"2013","unstructured":"Amate P, Huchon C, Dessapt AL, et al. Ovarian cancer: sites of recurrence. Int J Gynecol Cancer. 2013;23(9):1590\u20136.","journal-title":"Int J Gynecol Cancer."},{"issue":"12","key":"6464_CR19","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","volume":"13","author":"P Harter","year":"2006","unstructured":"Harter P, du Bois A, Hahmann M, et al. Surgery in recurrent ovarian cancer: the arbeitsgemeinschaft gynaekologische onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol. 2006;13(12):1702\u201310.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"6464_CR20","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.ygyno.2006.06.025","volume":"103","author":"RE Bristow","year":"2006","unstructured":"Bristow RE, Chi DS. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecol Oncol. 2006;103(3):1070\u20136.","journal-title":"Gynecol Oncol."},{"key":"6464_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J Prat","year":"2014","unstructured":"Prat J. Staging classification for the cancer of the ovary, fallopian tube and peritoneum. Int J Gynaecol Obstet. 2014;124:1\u20135.","journal-title":"Int J Gynaecol Obstet."},{"key":"6464_CR22","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1200\/JCO.2017.35.15_suppl.5500","volume":"35","author":"P Harter","year":"2017","unstructured":"Harter P, Sehouli J, Lorusso D, et al. LION: lymphadenectomy in ovarian neoplasms-A prospective randomized AGO study group led gynecologic cancer intergroup trial. J Clin Oncol. 2017;35:5500.","journal-title":"J Clin Oncol."},{"issue":"5","key":"6464_CR23","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1245\/s10434-014-3985-y","volume":"22","author":"JM Baumgartner","year":"2015","unstructured":"Baumgartner JM, Tobin L, Heavey SF, et al. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015;22(5):1716\u201321.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"6464_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1245\/s10434-011-1840-y","volume":"19","author":"H Halabi El","year":"2012","unstructured":"El Halabi H, Gushchin V, Francis J, et al. The role of cytoredcutive surgery and heated intraperitoneal chemotherapy (CRS\/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol. 2012;19(1):110\u20134.","journal-title":"Ann Surg Oncol."},{"key":"6464_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/01.sla.0000152015.76731.1f","volume":"241","author":"TJ Miner","year":"2005","unstructured":"Miner TJ, Shia J, Jacques DP, et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005;241:300\u20138.","journal-title":"Ann Surg."},{"issue":"12","key":"6464_CR26","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","volume":"39","author":"N Bakrin","year":"2013","unstructured":"Bakrin N, Bereder JM, Decullier E, Classe JM, et al. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol. 2013;39(12):1435\u201343.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"6464_CR27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ygyno.2011.05.009","volume":"122","author":"YY Lee","year":"2011","unstructured":"Lee YY, et al. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis. Gynecol Oncol. 2011;122(3):541\u20137.","journal-title":"Gynecol Oncol."},{"key":"6464_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.ygyno.2014.01.012","volume":"132","author":"M Davis","year":"2014","unstructured":"Davis M, Rauh-Hain JA, Andrade C, et al. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Gynecol Oncol. 2014;132:760\u20136.","journal-title":"Gynecol Oncol."},{"issue":"1","key":"6464_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00383-015-3814-9","volume":"32","author":"A Hayes-Jordan","year":"2016","unstructured":"Hayes-Jordan A, Lopez C, Green HL et al. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric ovarian tumors: a novel treatment approach. Pediatr Surg Int. 2016;32(1):71\u20133.","journal-title":"Pediatr Surg Int."},{"key":"6464_CR30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ygyno.2004.12.056","volume":"97","author":"D Pectasides","year":"2005","unstructured":"Pectasides D, Fountzilas G, Aravantinos G, et al. Advanced stage mucinous epithelial ovarian cancer: the Hellenic cooperative oncology group experience. Gynecol Oncol. 2005;97:436\u201341.","journal-title":"Gynecol Oncol."},{"issue":"480","key":"6464_CR31","first-page":"e1","volume":"205","author":"MB Schiavone","year":"2011","unstructured":"Schiavone MB, Herzog TJ, Lewin SN, et al. Natural history and outcome of mucinous carcinoma of the ovary. Am J Obstet Gynecol. 2011;205:480.e1\u20138.","journal-title":"Am J Obstet Gynecol."},{"key":"6464_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ygyno.2004.09.019","volume":"96","author":"JK Chan","year":"2005","unstructured":"Chan JK, Zhang M, Kaleb V, et al. Prognostic factors responsible for survival in sex cord stromal tumor of the ovary: a multivariate analysis. Gynecol Oncol. 2005;96:204\u20139.","journal-title":"Gynecol Oncol."},{"issue":"2","key":"6464_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ygyno.2017.05.020","volume":"146","author":"BL Seagle","year":"2017","unstructured":"Seagle BL, Ann P, Butler S, Shahabi S. Ovarian granulosa cell tumor: a National Cancer Database study. Gynecol Oncol. 2017;146(2):285\u201391.","journal-title":"Gynecol Oncol."},{"issue":"2","key":"6464_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ejogrb.2013.06.041","volume":"170","author":"S Gouy","year":"2013","unstructured":"Gouy S, Uzan C, Pautier P et al. Results of oxaliplatin-based hyperthermic intraperitoneal chemotherapy in recurrent ovarian granulosa cell tumors. Eur J Obstet Gynecol Reprod Biol. 2013;170(2):464\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"9","key":"6464_CR35","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1111\/jog.12460","volume":"40","author":"IA Al-Badawi","year":"2014","unstructured":"Al-Badawi IA, Abu-Zaid A, Azzam A, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management for recurrent\/relapsed ovarian granulosa cell tumor: a single center experience. J Obstet Gynaecol Res. 2014;40(9):2066\u201375.","journal-title":"J Obstet Gynaecol Res."},{"issue":"2","key":"6464_CR36","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/cncr.29732","volume":"122","author":"F Pashankar","year":"2016","unstructured":"Pashankar F, Hale JP, Dang H, et al. Is adjuvant chemotherapy indicated in ovarian immature teratoma? A combined data analysis from the malignant germ cell tumor international collaborative. Cancer. 2016;122(2):230\u20137.","journal-title":"Cancer."},{"issue":"5","key":"6464_CR37","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/IGC.0b013e3181a69a26","volume":"19","author":"O Poujade","year":"2009","unstructured":"Poujade O, Uzan C, Gouy S, et al. Primary\u00a0psammocarcinoma\u00a0of the ovary or\u00a0peritoneum. Int J Gynecol Cancer. 2009;19(5):844\u20136.","journal-title":"Int J Gynecol Cancer."},{"key":"6464_CR38","doi-asserted-by":"crossref","unstructured":"WItkowski L, Goudie C, Foulkes WD, McCluggage WG. Small-cell carcinoma of the ovary of hypercalcemic type (malignant rhabdoid tumor of the ovary): a review with recent development on pathogenesis. Surg Pathol Clin. 2016;9:215\u201326.","DOI":"10.1016\/j.path.2016.01.005"},{"issue":"20","key":"6464_CR39","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449\u201356.","journal-title":"J Clin Oncol."},{"key":"6464_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354:34\u201343.","journal-title":"N Engl J Med."},{"key":"6464_CR41","unstructured":"Walker JL, Brady MF, DiSilvestro PA, et al. A phase III trial of bevacizumab with IV versus IP chemotherapy in ovarian, fallopian tube, and peritoneal carcinoma NCI-supplied agent(s): A GOG\/NRG trial (GOG 252). 2016 Society of Gynecologic Oncology Annual Meeting. Late-breaking abstract 6. Presented March 21, 2016."},{"key":"6464_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ Driel Van","year":"2018","unstructured":"Van Driel, WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Eng J Med. 2018;378:230\u201340.","journal-title":"N Eng J Med."},{"key":"6464_CR43","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/jso.24248","volume":"113","author":"G Passot","year":"2016","unstructured":"Passot G, Vaudoyer D, Villeneuve L, et al. What made hyperthermic intraperitnoeal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1125 procedures. J Surg Oncol. 2016;113:796\u2013803.","journal-title":"J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6464-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T20:18:58Z","timestamp":1554841138000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6464-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["6464"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6464-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]},"assertion":[{"value":"24 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}